The results, which were published in the Lancet on Thursday, are very encouraging for the safety and efficacy of orforglipron in people with type 2 diabetes, says Daniel Drucker, an endocrinologist at the University of Toronto, adding that he is awaiting further clinical trial results of the drug in people with obesity
In trials, retatrutide produced higher weight loss than Wegovy at the highest dose of each: 28.7% at 68 weeks on retatrutide 12 mg, versus 20.7% at 72 weeks on the newer Wegovy 7.2 mg dose, and 14.9% at 68 weeks on the older Wegovy 2.4 mg dose
The effectiveness of tirzepatide comes from maintaining a consistent steady state in your blood over many months
The medications arrive usually within a week or so and subsequent prescriptions can be timed so that you do not miss a dose
Most clients go straight back to work, errands, or the school run
And there is great variability in how much medical advice and support such online businesses provide, said Sarah Le Brocq of All About Obesity, a patient support group